Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Efficacy and safety of Synolis VA for hip osteoarthritis

Official title: 6-month Evaluation of the Efficacy and Safety of Synolis VA 80/160 in the Treatment of Symptomatic Hip Osteoarthritis

Run by Aptissen SA · NCT05829733 · Data updated 2026-11-12

This study is testing if a new treatment called Synolis VA can help people with hip osteoarthritis feel less pain and move better over six months.

More Osteoarthritis, Hip trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorAptissen SA
Industry-sponsored
Locations3 sites (Belfort and 2 other locations)
StatusRecruiting
StartedMay 27, 2024
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedDecember 12, 2025
Trial IDNCT05829733 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with a diagnosis of hip osteoarthritis who have not responded to standard analgesics or NSAIDs.

Probably not a fit

Patients who are pregnant, have had recent infections in the affected joint, or are scheduled for hip surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter study evaluates the efficacy and safety of Synolis VA 80/160 in patients with hip osteoarthritis over a 6-month period. Participants will receive the treatment and be monitored for improvements in hip pain and function, as well as any potential side effects. The study aims to determine whether this hyaluronic acid-based intervention can provide relief for patients who have not responded adequately to other treatments.

Why it matters

Potential benefit: If successful, this treatment could significantly improve pain management and quality of life for patients suffering from hip osteoarthritis.

How similar studies have gone: Previous studies on hyaluronic acid treatments for osteoarthritis have shown varying degrees of success, indicating potential but also the need for further investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient over 18 years of age,
* Patient with osteoarthritis of the hip. The diagnosis is based on the following criteria:
* Treated hip pain: Oxford score ≥ 21/60,
* Kellgren-Lawrence positive X-ray stage: II - III (inclusion radiograph dated no more than 6 months before the inclusion visit),
* Symptoms related to osteoarthritis of the hip for at least 2 months,
* Failure of treatments (i.e., inadequate or ineffective response to analgesics and/or NSAIDs or intolerance to NSAIDs or low-grade opioids (leaving an OXFORD score ≥ 21/60),
* Informed consent form signed by the patient,
* The patient has never had a visco supplement injection or corticosteroid injection in the hip to be treated (or more than 6 months old).

Exclusion Criteria:

* Pregnancy,
* Participation in another clinical trial,
* Skin lesion near the injection site,
* Recent or old infection of the affected joint,
* Patient with a programmed arthroplasty,
* Patient with a pathology that makes decision-making impossible,
* The patient must not have undergone non-prosthetic hip-conserving surgery such as osteotomy or arthroscopy less than 12 months old.

Where it's running

  • Service de Rhumatologie, Hôpital Nord Franche-Comté
    Belfort, France
    Recruiting
  • Service de chirurgie orthopédique et traumatologie Centre Hospitalier de Dunkerque CHD
    Dunkirk, France
    Recruiting
  • Service d'Orthopédie II (Membre Inférieur, Chirurgie du Sport et Chirurgie Septique) Hôpital Salengro, CHRU de Lille
    Lille, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.